CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-12 | Alenson Carman Principal Accounting Officer | Option exercise · Stock option (right to buy) | −2,150 | 12,850 | ||
| 2018-01-10 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $0.47 | $1K | 56,059 |
| 2018-01-10 | Biller Scott Chief Scientific Officer | Sale | −3,000 | $65.00 | $195K | 53,059 |
| 2018-01-10 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | −3,000 | 1,867 | ||
| 2017-12-07 | Cantley Lewis Clayton Jr. Director | Sale | −288 | $59.68 | $17K | 80,106 |
| 2017-12-07 | Cantley Lewis Clayton Jr. Director | Sale | −288 | $59.68 | $17K | 80,146 |
| 2017-12-07 | Cantley Lewis Clayton Jr. Director | Sale | −631 | $60.45 | $38K | 79,475 |
| 2017-12-07 | Cantley Lewis Clayton Jr. Director | Sale | −631 | $60.45 | $38K | 79,515 |
| 2017-12-06 | Cantley Lewis Clayton Jr. Director | Sale | −543 | $57.90 | $31K | 80,851 |
| 2017-12-06 | Cantley Lewis Clayton Jr. Director | Sale | −542 | $57.90 | $31K | 80,892 |
| 2017-12-06 | Cantley Lewis Clayton Jr. Director | Sale | −253 | $58.95 | $15K | 80,598 |
| 2017-12-06 | Cantley Lewis Clayton Jr. Director | Sale | −254 | $58.95 | $15K | 80,638 |
| 2017-12-06 | Cantley Lewis Clayton Jr. Director | Sale | −204 | $60.01 | $12K | 80,394 |
| 2017-12-06 | Cantley Lewis Clayton Jr. Director | Sale | −204 | $60.01 | $12K | 80,434 |
| 2017-12-06 | Biller Scott Chief Scientific Officer | Option exercise | +14,875 | $0.47 | $7K | 21,139 |
| 2017-12-06 | Biller Scott Chief Scientific Officer | Option exercise | +102 | $0.47 | $48 | 21,241 |
| 2017-12-06 | Biller Scott Chief Scientific Officer | Option exercise | +31,818 | $2.34 | $74K | 53,059 |
| 2017-12-06 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | +14,875 | 0 | ||
| 2017-12-06 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | +102 | 4,867 | ||
| 2017-12-06 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | +31,818 | 31,818 |
Page 69 of 80 · 1,590 trades